Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Plasma Exchange × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

ravulizumab 4 zilucoplan 3 rozanolixizumab 3 fludarabine 2 Cyclophosphamide 2 telitacicept 1 talquetamab 1 remibrutinib 1 iptacopan 1 inebilizumab 1 efgartigimod alfa 1 Prednisone 1 Prednisolone 1 Plasma Exchange 1 Immunoglobulins, Intravenous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07532707 2026-04-16

Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.

Damascus University

Phase NA Completed

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡